4.4 Article

Discovery and development of avotermin (recombinant human transforming growth factor beta 3): A new class of prophylactic therapeutic for the improvement of scarring

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

New therapeutics for the prevention and reduction of scarring

Nick L. Occleston et al.

DRUG DISCOVERY TODAY (2008)

Article Cell Biology

Site-specific production of TGF-beta in oral mucosal and cutaneous wounds

Megan E. Schrementi et al.

WOUND REPAIR AND REGENERATION (2008)